BridgeBio Oncology Therapeutics Inc.
(BBOT - NASDAQ)
8,79 USD
📋 Profilo Aziendale

BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors.

|